Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Lannett's abbreviated new drug application (ANDA) of Phentermine HCl Capsules, 37.5mg.
Subscribe to our email newsletter
Lannett’s Phentermine HCl Capsules, 37.5mg is the generic version of Teva Pharmaceuticals USA’s Adipex-P Capsules, 37.5mg.
Phentermine Hydrochloride (HCl) is used for the short-term management of obesity.
Lannett president and CEO Arthur Bedrosian said with the approval of Phentermine HCl Capsules, 37.5mg, they now offer a full portfolio, including 12 SKUs, of anti-obesity products.
"This is our second drug approval within the last few days; we now have 15 ANDAs currently pending at the FDA," Bedrosian said.